CA1030951A - 8.alpha.-OESTRATRIENES OXYGENES EN 1,3 - Google Patents

8.alpha.-OESTRATRIENES OXYGENES EN 1,3

Info

Publication number
CA1030951A
CA1030951A CA204,667A CA204667A CA1030951A CA 1030951 A CA1030951 A CA 1030951A CA 204667 A CA204667 A CA 204667A CA 1030951 A CA1030951 A CA 1030951A
Authority
CA
Canada
Prior art keywords
oestratrienes
oxygenated
alpha
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA204,667A
Other languages
English (en)
Inventor
Klaus Prezewowsky
Henry Laurent
Friedmund Neumann
Rudolf Wiechert
Helmut Hofmeister
Yukishige Nishino
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2336431A external-priority patent/DE2336431C2/de
Priority claimed from DE19742426777 external-priority patent/DE2426777A1/de
Application filed by Schering AG filed Critical Schering AG
Application granted granted Critical
Publication of CA1030951A publication Critical patent/CA1030951A/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0074—Esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0059—Estrane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J15/00—Stereochemically pure steroids containing carbon, hydrogen, halogen or oxygen having a partially or totally inverted skeleton, e.g. retrosteroids, L-isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0072—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the A ring of the steroid being aromatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Catalysts (AREA)
CA204,667A 1973-07-13 1974-07-12 8.alpha.-OESTRATRIENES OXYGENES EN 1,3 Expired CA1030951A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2336431A DE2336431C2 (de) 1973-07-13 1973-07-13 1.3-oxygenierte 8 alpha-Östratriene, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE19742426777 DE2426777A1 (de) 1974-05-31 1974-05-31 1.3-oxygenierte 8 alpha-oestratriene

Publications (1)

Publication Number Publication Date
CA1030951A true CA1030951A (fr) 1978-05-09

Family

ID=25765510

Family Applications (1)

Application Number Title Priority Date Filing Date
CA204,667A Expired CA1030951A (fr) 1973-07-13 1974-07-12 8.alpha.-OESTRATRIENES OXYGENES EN 1,3

Country Status (18)

Country Link
JP (1) JPS5821639B2 (fr)
AT (1) ATA575574A (fr)
AU (1) AU477010B2 (fr)
CA (1) CA1030951A (fr)
CH (2) CH609064A5 (fr)
CS (2) CS182260B2 (fr)
DD (1) DD114066A5 (fr)
DK (1) DK133051C (fr)
ES (1) ES428226A1 (fr)
FI (1) FI54131C (fr)
FR (1) FR2236505B1 (fr)
GB (1) GB1479934A (fr)
HU (1) HU169791B (fr)
IE (1) IE39872B1 (fr)
IL (1) IL45259A (fr)
NO (1) NO742546L (fr)
SE (1) SE7409151L (fr)
SU (1) SU626705A3 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2551214C2 (de) * 1975-11-12 1984-07-12 Schering AG, 1000 Berlin und 4709 Bergkamen Verfahren zur Herstellung von 1,3-oxygenierten 8α-Östratrienen
JPS5862734U (ja) * 1981-10-22 1983-04-27 日工株式会社 型枠支持サボ−ト
JPS59146759A (ja) * 1984-01-06 1984-08-22 株式会社日立製作所 自動ねじ込み装置
JPS60155376A (ja) * 1984-01-24 1985-08-15 松下電器産業株式会社 ナツト浮き検出装置
DE3710728A1 (de) * 1987-03-31 1988-10-13 Schering Ag Verfahren zur herstellung von 17(alpha)-ethinyl-17ss-hydroxy-18-methyl-4,15-estradien-3-on und die neuen zwischenprodukte fuer dieses verfahren
US6011024A (en) 1991-08-28 2000-01-04 Imperial College Of Science Technology & Medicine Steroid sulphatase inhibitors
US6476011B1 (en) 1991-08-28 2002-11-05 Sterix Limited Methods for introducing an estrogenic compound
US6903084B2 (en) 1991-08-29 2005-06-07 Sterix Limited Steroid sulphatase inhibitors
US7335650B2 (en) 2000-01-14 2008-02-26 Sterix Limited Composition
GB0020498D0 (en) 2000-08-18 2000-10-11 Sterix Ltd Compound
RU2679625C1 (ru) * 2018-11-08 2019-02-12 Ильясов Шамиль Сионович ПРИМЕНЕНИЕ 3-О-СУЛЬФАМОИЛОКСИ-6-ОКСА-7β-МЕТИЛ-D-ГОМО-8α-ЭСТРА-1,3,5(10)-ТРИЕН-17а-ОНА ДЛЯ ЛЕЧЕНИЯ РАКА МОЛОЧНОЙ ЖЕЛЕЗЫ, ВКЛЮЧАЯ ТРИЖДЫ-НЕГАТИВНУЮ ФОРМУ, И СПОСОБ ЕГО ПОЛУЧЕНИЯ

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3436411A (en) * 1967-12-28 1969-04-01 American Home Prod Process for cleaving an a-ring ether group in 13-alkylgona (and 8-isogona)-1,3,5(10)-trienes and delta-7-,delta-8(9)-,and delta-8(9),14(15)-dehydro derivatives thereof

Also Published As

Publication number Publication date
IL45259A0 (en) 1974-10-22
IL45259A (en) 1977-10-31
SE7409151L (sv) 1975-01-14
FR2236505A1 (fr) 1975-02-07
ATA575574A (de) 1978-05-15
HU169791B (en) 1977-01-28
JPS5032160A (fr) 1975-03-28
CS182260B2 (en) 1978-04-28
DK133051B (da) 1976-03-15
ES428226A1 (es) 1976-07-16
DK368074A (fr) 1975-03-17
AU7112374A (en) 1976-01-15
FR2236505B1 (fr) 1977-07-08
AU477010B2 (en) 1976-10-14
DD114066A5 (fr) 1975-07-12
CH614217A5 (en) 1979-11-15
FI213974A (fr) 1975-01-14
NO742546L (fr) 1975-02-10
IE39872L (en) 1975-01-13
DK133051C (da) 1976-08-16
FI54131C (fi) 1978-10-10
FI54131B (fi) 1978-06-30
JPS5821639B2 (ja) 1983-05-02
CH609064A5 (en) 1979-02-15
GB1479934A (en) 1977-07-13
IE39872B1 (en) 1979-01-17
SU626705A3 (ru) 1978-09-30
CS182300B2 (en) 1978-04-28

Similar Documents

Publication Publication Date Title
IE39302L (en) 1,4- diazacycloheptanes.
CA1030951A (fr) 8.alpha.-OESTRATRIENES OXYGENES EN 1,3
CA1030950A (fr) 8.alpha.-OESTRATRIENES OXYGENES EN 1,3
CA1016176A (en) .alpha.-CYCLOALKYLBENZYL LACTAMIMIDES
CA1008076A (en) .alpha.-ALKYLBENZYL LACTAMIMIDES
CA1034572A (fr) Nor-6 alkyl-6 dihydro-9,10 methyl-2'b benzyl-5'd ergopeptine
CA1027929A (fr) 7-alkyle-.delta.3,5-steroides
CA1033716A (fr) 17b hydroxy-16, 16-dimethylestr-4-en-3-one
CA963000A (en) 15.alpha.,16.alpha.-METHYLENE-STEROIDS
CA1009666A (en) 2,5,5-trimethyl-hepta-2,6-dienal
CA1018967A (en) 15.alpha., 16.alpha.-METHYLENE-.DELTA.4-PREGNENES
CA1024140A (fr) Anilino-6 trihydroxyanthraquinones-1,4,5
AU503626B2 (en) Substituted 1, 5-diphenyl-3-formazancarbonitriles
CA1018157A (en) 8,8'-dioxo-6,6'-azopurine
AU472337B2 (en) 11, 12-secoprostaglandins
AU467306B2 (en) 15, 16-methylene-4-oestren-17 -ols
CA1031779A (fr) Thiadiazol-1,3,4-yl-2 urees a action herbicide specifique
AU478074B2 (en) 1,3-oxygenated s-oestratrienes
AU489033B2 (en) HERDICIDAL l, 3, 4-THIADIAZOL-2-YL-UREAS
CA894792A (en) .alpha.-AMINO-2,4,6-CYCLOHEPTATRIENYLMETHYLPENICILLINS
AU5701673A (en) 3, 4-dialkanyloxyphenyl)-l-alanines
CA1010861A (en) 9.beta.-HYDROXY-5-METHYL-6,7-BENZOMORPHANS
AU7206674A (en) 2, 2-disubstitute-benzodioxoles
AU478213B2 (en) 17b- hydroxy-16, 16-dimethylester-4-en-3-one
CA992960A (en) 2,2'-anhydro-b-d-arabinofuranosyl-5-fluorocytosine